Claudio XOMPERO, Walid BENETTAYEB, Eric H. SOUIED, Carl-Joe MEHANNA
{"title":"评估基于 ChatGPT 的眼科教育工具 MonŒil 可用性的试点研究","authors":"Claudio XOMPERO, Walid BENETTAYEB, Eric H. SOUIED, Carl-Joe MEHANNA","doi":"10.1016/j.ajoint.2024.100032","DOIUrl":null,"url":null,"abstract":"<div><h3>Importance</h3><p>There is an increasing use of artificial intelligence (AI) in ophthalmology to respond to the needs of patients to access reliable, easy-to-understand medical information.</p></div><div><h3>Objective</h3><p>To assess patient satisfaction with the usability of MonŒil, an AI-based platform designed for patient education in ophthalmology.</p></div><div><h3>Design</h3><p>This was a pilot cross-sectional study of the usability of MonŒil by patients followed for advanced age-related macular degeneration (AMD). MonŒil is based on ChatGPT-4 technology with specific ophthalmology-focused customizations and accessibility enhancements, and is freely available at <em>monoeil.help</em>. Patients were given 20 min of unsupervised interaction with no prior training or guidance, after which their feedback was collected.</p></div><div><h3>Setting</h3><p>The study was performed in the ophthalmology department at the Creteil University Hospital.</p></div><div><h3>Participants</h3><p>Participants included 54 patients diagnosed with advanced AMD defined presenting for follow-up. Patients had to be older than 50 years of age, capable of giving informed consent, and able to understand and interact with MonŒil. Exclusion criteria were severe visual and cognitive impairment that prevented interaction with MonŒil.</p></div><div><h3>Main Outcome(s) and Measure(s)</h3><p>The primary outcome was the usability of MonŒil as measured by the System Usability Scale (SUS) questionnaire.</p></div><div><h3>Results</h3><p>Of the 54 participants, 34 were female (62.96 %). The mean age of the cohort was 77.76±8.14 years (range 58 to 97 years). The mean SUS score was 90.23±12.04 with a median of 92.50 (range 42.50 to 100.00), indicating excellent usability. There was a positive relationship between visual acuity and SUS score (regression coefficient 0.30 (95 % CI 0.08 to 0.51), r2=0.19, <em>p</em> = 0.0077).</p></div><div><h3>Conclusions and Relevance</h3><p>MonŒil demonstrated excellent usability and satisfaction in a sample population of elderly patients with advanced AMD. These results suggest that AI-based tools like MonŒil can enhance patient education with minimal oversight in a complex field like ophthalmology, supporting its use as an adjunct to the physician-patient discussion. Further studies may be necessary to establish the applicability of MonŒil to a broader user base, and to assess its usefulness and clinical impact on patient outcomes such as patient knowledge and vision-related quality of life.</p></div>","PeriodicalId":100071,"journal":{"name":"AJO International","volume":"1 2","pages":"Article 100032"},"PeriodicalIF":0.0000,"publicationDate":"2024-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2950253524000327/pdfft?md5=0d565968f77c687abb04b1d701e28a80&pid=1-s2.0-S2950253524000327-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Pilot study evaluating the usability of MonŒil, a ChatGPT-based education tool in ophthalmology\",\"authors\":\"Claudio XOMPERO, Walid BENETTAYEB, Eric H. SOUIED, Carl-Joe MEHANNA\",\"doi\":\"10.1016/j.ajoint.2024.100032\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Importance</h3><p>There is an increasing use of artificial intelligence (AI) in ophthalmology to respond to the needs of patients to access reliable, easy-to-understand medical information.</p></div><div><h3>Objective</h3><p>To assess patient satisfaction with the usability of MonŒil, an AI-based platform designed for patient education in ophthalmology.</p></div><div><h3>Design</h3><p>This was a pilot cross-sectional study of the usability of MonŒil by patients followed for advanced age-related macular degeneration (AMD). MonŒil is based on ChatGPT-4 technology with specific ophthalmology-focused customizations and accessibility enhancements, and is freely available at <em>monoeil.help</em>. Patients were given 20 min of unsupervised interaction with no prior training or guidance, after which their feedback was collected.</p></div><div><h3>Setting</h3><p>The study was performed in the ophthalmology department at the Creteil University Hospital.</p></div><div><h3>Participants</h3><p>Participants included 54 patients diagnosed with advanced AMD defined presenting for follow-up. Patients had to be older than 50 years of age, capable of giving informed consent, and able to understand and interact with MonŒil. Exclusion criteria were severe visual and cognitive impairment that prevented interaction with MonŒil.</p></div><div><h3>Main Outcome(s) and Measure(s)</h3><p>The primary outcome was the usability of MonŒil as measured by the System Usability Scale (SUS) questionnaire.</p></div><div><h3>Results</h3><p>Of the 54 participants, 34 were female (62.96 %). The mean age of the cohort was 77.76±8.14 years (range 58 to 97 years). The mean SUS score was 90.23±12.04 with a median of 92.50 (range 42.50 to 100.00), indicating excellent usability. There was a positive relationship between visual acuity and SUS score (regression coefficient 0.30 (95 % CI 0.08 to 0.51), r2=0.19, <em>p</em> = 0.0077).</p></div><div><h3>Conclusions and Relevance</h3><p>MonŒil demonstrated excellent usability and satisfaction in a sample population of elderly patients with advanced AMD. These results suggest that AI-based tools like MonŒil can enhance patient education with minimal oversight in a complex field like ophthalmology, supporting its use as an adjunct to the physician-patient discussion. Further studies may be necessary to establish the applicability of MonŒil to a broader user base, and to assess its usefulness and clinical impact on patient outcomes such as patient knowledge and vision-related quality of life.</p></div>\",\"PeriodicalId\":100071,\"journal\":{\"name\":\"AJO International\",\"volume\":\"1 2\",\"pages\":\"Article 100032\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-05-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2950253524000327/pdfft?md5=0d565968f77c687abb04b1d701e28a80&pid=1-s2.0-S2950253524000327-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"AJO International\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2950253524000327\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"AJO International","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2950253524000327","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
重要性人工智能(AI)在眼科领域的应用越来越广泛,以满足患者获取可靠、易懂的医疗信息的需求。目的评估患者对MonŒil(一个基于人工智能的眼科患者教育平台)可用性的满意度。MonŒil以ChatGPT-4技术为基础,针对眼科进行了专门定制并增强了可访问性,可在monoeil.help上免费获取。研究在克里特大学医院的眼科进行。参与者包括 54 名被诊断为晚期 AMD 的患者,他们都是来复诊的。患者年龄必须在 50 岁以上,能够做出知情同意,能够理解 MonŒil 并与之互动。排除标准是有严重视力和认知障碍,无法与MonŒil互动。主要结果和测量指标主要结果是MonŒil的可用性,通过系统可用性量表(SUS)问卷进行测量。平均年龄为(77.76±8.14)岁(58 至 97 岁)。平均 SUS 得分为 90.23±12.04,中位数为 92.50(范围为 42.50 至 100.00),表明可用性极佳。视力与 SUS 分数之间存在正相关关系(回归系数为 0.30(95 % CI 0.08 至 0.51),r2=0.19,p = 0.0077)。这些结果表明,像MonŒil这样基于人工智能的工具可以在像眼科这样复杂的领域以最小的监督加强患者教育,支持将其作为医患讨论的辅助工具。可能有必要开展进一步研究,以确定MonŒil是否适用于更广泛的用户群,并评估其实用性及其对患者知识和视力相关生活质量等患者结果的临床影响。
Pilot study evaluating the usability of MonŒil, a ChatGPT-based education tool in ophthalmology
Importance
There is an increasing use of artificial intelligence (AI) in ophthalmology to respond to the needs of patients to access reliable, easy-to-understand medical information.
Objective
To assess patient satisfaction with the usability of MonŒil, an AI-based platform designed for patient education in ophthalmology.
Design
This was a pilot cross-sectional study of the usability of MonŒil by patients followed for advanced age-related macular degeneration (AMD). MonŒil is based on ChatGPT-4 technology with specific ophthalmology-focused customizations and accessibility enhancements, and is freely available at monoeil.help. Patients were given 20 min of unsupervised interaction with no prior training or guidance, after which their feedback was collected.
Setting
The study was performed in the ophthalmology department at the Creteil University Hospital.
Participants
Participants included 54 patients diagnosed with advanced AMD defined presenting for follow-up. Patients had to be older than 50 years of age, capable of giving informed consent, and able to understand and interact with MonŒil. Exclusion criteria were severe visual and cognitive impairment that prevented interaction with MonŒil.
Main Outcome(s) and Measure(s)
The primary outcome was the usability of MonŒil as measured by the System Usability Scale (SUS) questionnaire.
Results
Of the 54 participants, 34 were female (62.96 %). The mean age of the cohort was 77.76±8.14 years (range 58 to 97 years). The mean SUS score was 90.23±12.04 with a median of 92.50 (range 42.50 to 100.00), indicating excellent usability. There was a positive relationship between visual acuity and SUS score (regression coefficient 0.30 (95 % CI 0.08 to 0.51), r2=0.19, p = 0.0077).
Conclusions and Relevance
MonŒil demonstrated excellent usability and satisfaction in a sample population of elderly patients with advanced AMD. These results suggest that AI-based tools like MonŒil can enhance patient education with minimal oversight in a complex field like ophthalmology, supporting its use as an adjunct to the physician-patient discussion. Further studies may be necessary to establish the applicability of MonŒil to a broader user base, and to assess its usefulness and clinical impact on patient outcomes such as patient knowledge and vision-related quality of life.